Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS · Delayed Price · Currency is USD
0.00
0.00 (0.00%)
Aug 12, 2025, 4:00 PM EDT
Accelerate Diagnostics Employees
Accelerate Diagnostics had 107 employees as of December 31, 2024. The number of employees decreased by 27 or -20.15% compared to the previous year.
Employees
107
Change (1Y)
-27
Growth (1Y)
-20.15%
Revenue / Employee
$109,327
Profits / Employee
-$467,710
Market Cap
25.00
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 107 | -27 | -20.15% |
Dec 31, 2023 | 134 | -45 | -25.14% |
Dec 31, 2022 | 179 | -41 | -18.64% |
Dec 31, 2021 | 220 | -4 | -1.79% |
Dec 31, 2020 | 224 | -51 | -18.55% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
Accelerate Diagnostics News
- 3 months ago - Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - PRNewsWire
- 5 months ago - Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PRNewsWire
- 5 months ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 7 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 9 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 10 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 11 months ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire